Mitiglinide: A Novel Agent for the Treatment of Type 2 Diabetes Mellitus

Multicentre, Double-blind, Randomized Study of Mitiglinide Compared with Nateglinide in Type 2 Diabetes Mellitus Patients in China

(2013) X Gao et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Pleiotropic Effects of Mitiglinide in Type 2 Diabetes Mellitus

(2013) H Konya et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Treatment with Glimepiride, but not Mitiglinide and Short-Acting Insulin, Resists Body Weight and Abdominal Fat Reduction Under Dietary Energy Restriction

(2011) Takanari Nakano et al.   Journal of Atherosclerosis and Thrombosis

Effect of Mitiglinide on Glycemic Control over 52 Weeks in Japanese Type 2 Diabetic Patients Insufficiently Controlled with Pioglitazone Monotherapy

(2009) Kohei KAKU et al.   ENDOCRINE JOURNAL

Addition of Mitiglinide to Pioglitazone Monotherapy Improves Overall Glycemic Control in Japanese Patients with Type 2 Diabetes: A Randomized Double Blind Trial

(2009) Kohei KAKU et al.   ENDOCRINE JOURNAL

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patients

(2008) Willy J Malaisse   EXPERT OPINION ON PHARMACOTHERAPY